KimKramerMD

Pediatric Hematology & Oncology • New York, NY

Physician

Overview of Dr. Kramer

Dr. Kim Kramer is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and New York-Presbyterian Hospital. She received her medical degree from SUNY Upstate Medical University and has been in practice 28 years. She is one of 92 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at NYC Health + Hospitals / Bellevue who specialize in Pediatric Hematology & Oncology. She has more than 100 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Book by Phone+1(313) 528-0687
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of RochesterFellowship, Pediatric Hematology/Oncology, 1992 - 1993
University of RochesterResidency, Pediatrics, 1989 - 1992
SUNY Upstate Medical UniversityClass of 1989

Certifications & Licensure

NY State Medical License 1993 - 2026
NC State Medical License 2021 - 2022
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer Start of enrollment: 1997 Apr 01
Completed
Phase 1
Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer Start of enrollment: 2004 Feb 05
Terminated
Phase 1
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Start of enrollment: 2006 Jan 01
Completed
Phase 2
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Start of enrollment: 2015 Sep 01
Active, not recruiting
Phase 4
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.
Kavya Prasad, Brian E Serencsits, Bae P Chu, Lawrence T Dauer, Maria Donzelli, Ellen Basu, Kim Kramer, Neeta Pandit-Taskar> ;Research Square. 2024 Feb 28
4 citations
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan J Robison, Lindsay Kilburn, Anna Vi...> ;Neuro-Oncology. 2023 Dec 8
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
Kathryn R Tringale, Suzanne L Wolden, Matthias Karajannis, Sofia Haque, Luca Pasquini, Onur Yildirim, Marc Rosenblum, Jamal K Benhamida, Nai-Kong Cheung, Mark Souweida...> ;Journal of Neuro-Oncology. 2023 Mar 1
3 citations
Immunotherapy with anti-Gmonoclonal antibody in infants with high-risk neuroblastoma.
Brian H Kushner, Shakeel Modak, Kim Kramer, Ellen M Basu, Fiorella Iglesias-Cardenas, Stephen S Roberts, Nai-Kong V Cheung> ;International Journal of Cancer. 2023 Jan 15
16 citations
Phase 1 study of intraventricularI-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
Kim Kramer, Neeta Pandit-Taskar, Brian H Kushner, Pat Zanzonico, John L Humm, Ursula Tomlinson, Maria Donzelli, Suzanne L Wolden, Sophia Haque, Ira Dunkel, Mark M Souw...> ;Journal of Hematology & Oncology. 2022 Nov 12
1 citations
Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device.
Sheila S McThenia, Neeta Pandit-Taskar, Milan Grkovski, Maria A Donzelli, Safiatu Diagana, Jeffrey P Greenfield, Mark M Souweidane, Kim Kramer> ;Journal of Neuro-Oncology. 2022 May 1
Carboplatin During Craniospinal Radiotherapy for Children With Group 3 Medulloblastoma-A New Standard of Care?
Matthias A Karajannis, Audrey Mauguen, Kim Kramer> ;JAMA Oncology. 2022 Feb 1
5 citations
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.
Fiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, Kim Kramer, Brian H Kushner, Govind Ragupathi, Nai-Kong V Cheung, Shakeel Modak> ;Cancers. 2021 Dec 14
Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy
Kim Kramer, Maria Donzelli, Melissa S. Pessin> ;Cancer Immunology, Immunotherapy. 2021 Apr 30
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.
Kim Kramer, Maria Donzelli, Melissa S. Pessin> ;Cancer Immunology, Immunotherapy. 2021 Feb 3
8 citations
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab—pharmacokinetic modeling to optimize therapeutic index
Ping He, Edward K Fung, Kim Kramer, Pat Zanzonico, John L. Humm, Hong-fen Guo, Neeta Pandit-Taskar, Steven M. Larson, Nai-Kong V. Cheung> ;European Journal of Nuclear Medicine and Molecular Imaging. 2021 Apr 1
569 citations
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez, Constantinos P. Zambirinis, Gonçalo Rodrigues, Henrik Molina, Søren H...> ;Cell. 2020 Aug 20
7 citations
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma
L. Luo, Kim Kramer, Nai-Kong V. Cheung, Brian H. Kushner, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Suzanne L. Wolden> ;Pediatric Blood & Cancer. 2020 Sep 1
47 citations
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Tabitha Cooney, Kenneth J. Cohen, Carolina V. Guimaraes, Girish Dhall, James L. Leach, Maura Massimino, Alessandra Erbetta, Luisa Chiapparini, Fatema Malbari, Kim Kram...> ;The Lancet. Oncology. 2020 Jun 1
3 citations
Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy
Kim Kramer, Maria Donzelli, Emmanuela Nwora, Neeta Pandit-Taskar> ;Journal of Nuclear Medicine. 2020 May 1
23 citations
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.
Neeta Pandit-Taskar, Pat Zanzonico, Kim Kramer, Milan Grkovski, Edward K. Fung, Weiji Shi, Zhigang Zhang, Serge K. Lyashchenko, Alex Mak Fung, Keith S. Pentlow, Jorge ...> ;Journal of Nuclear Medicine. 2019 Dec 1
1 citations
Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy
Kim Kramer, Osman Khan, Sofia Haque> ;Journal of Neuro-Oncology. 2019 Jul 16
20 citations
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.
Kayleen Bailey, Neeta Pandit-Taskar, John L. Humm, Pat Zanzonico, Stephen Gilheeney, Nai-Kong V. Cheung, Kim Kramer> ;Journal of Neuro-Oncology. 2019 Mar 16
164 citations
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M. Souweidane, Kim Kramer, Neeta Pandit-Taskar, Zhiping Zhou, Sofia Haque, Jorge A. Carrasquillo, Serge K. Lyashchenko, Sunitha B. Thakur, Maria Donzelli, Ryan S ...> ;The Lancet. Oncology. 2018 Aug 1
55 citations
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.
Shakeel Modak, Jean-Benoît Le Luduec, Irene Y. Cheung, Debra A. Goldman, Irina Ostrovnaya, Ekaterina Doubrovina, Ellen M. Basu, Brian H. Kushner, Kim Kramer, Stephen S...> ;Oncoimmunology. 2018 May 10
17 citations
Treatment and outcome of adult-onset neuroblastoma
Maya Suzuki, Brian H. Kushner, Kim Kramer, Ellen M. Basu, Stephen S. Roberts, William J. Hammond, Michael P. LaQuaglia, Suzanne L. Wolden, Nai-Kong V. Cheung, Shakeel ...> ;International Journal of Cancer. 2018 Sep 1
35 citations
A phase II study of radioimmunotherapy with intraventricular 131I-3F8 for medulloblastoma
Kim Kramer, Neeta Pandit-Taskar, John L. Humm, Pat Zanzonico, Sofia Haque, Ira J. Dunkel, Suzanne L. Wolden, Maria Donzelli, Debra A. Goldman, Jason S. Lewis, Serge K....> ;Pediatric Blood & Cancer. 2018 Jan 1
26 citations
Central nervous system relapse of rhabdomyosarcoma.
Brian De, Michael D. Kinnaman, Leonard H. Wexler, Kim Kramer, Suzanne L. Wolden> ;Pediatric Blood & Cancer. 2018 Jan 1
8 citations
MYCN -amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G D2 immunotherapy.
Brian H. Kushner, Michael P. LaQuaglia, Shakeel Modak, Suzanne L. Wolden, Ellen M. Basu, Stephen S. Roberts, Kim Kramer, Karima Yataghene, Irene Y. Cheung, Nai-Kong V....> ;Oncotarget. 2017 Aug 27
48 citations
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J. Becher, Stephen Gilheeney, Yasmin Khakoo, David Lyden, Sofia Haque, Kevin C. De Braganca, Jill M. Kolesar, Jason T. Huse, Shakeel Modak, Leonard H. Wexler, Kim...> ;Pediatric Blood & Cancer. 2017 Jul 1
Join now to see all

Lectures

Intraventricular radioimmunotherapy targeting B7H3 for CNS malignancies.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Y-mAbs Announces Update on Naxitamab and Omburtamab in NeuroblastomaOctober 16th, 2020
Y-mAbs Announces Positive Omburtamab Clinical DataOctober 28th, 2019
Finding a Cure for Children with CNS NeuroblastomaJuly 22nd, 2019
Join now to see all

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York
NYC Health + Hospitals / BellevueNew York, New York
New York-Presbyterian HospitalNew York, New York